| Donna Baker, CRNA | |
|
6701 N Charles St, Towson, MD 21204-6808 | |
| (410) 296-4616 | |
| (410) 337-5068 |
| Full Name | Donna Baker |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 44 Years |
| Location | 6701 N Charles St, Towson, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396747838 | NPI | - | NPPES |
| R087555 | Other | MD | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R087555 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthomed Staffing Llc | 9638429178 | 237 |
News Archive
A shorter anti-malaria treatment is as effective in treating seriously ill children as the standard regimen, according to new research. Researchers have shown that three doses over two days of the drug artesunate are as effective in killing the malaria parasite in the blood as five doses over three days.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).
A small blood lab that fits into the pocket of a jacket can quickly analyze the risk of blood clots in legs prior to a long distance flight; a sensor wristband for measuring electric smog can warn pacemaker patients of life-threatening exposure: "Smart plastics" can turn such tools into reality.
Even though the use of implantable devices for the treatment of heart failure and heart rhythm disturbances has increased enormously in Europe in recent years, there still remain large differences between countries. Indeed, a report last year in the European Journal of Heart Failure found that there is an underuse of devices in many of the European countries surveyed. This is especially so in the emerging economies of Eastern Europe.
First peer-reviewed publication on US trial results from Houston Methodist published in The American Journal of Pathology
› Verified 8 days ago
| Entity Name | Anesthesia Consultants Of Central Florida,llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578681664 PECOS PAC ID: 5092813410 Enrollment ID: O20070608000407 |
News Archive
A shorter anti-malaria treatment is as effective in treating seriously ill children as the standard regimen, according to new research. Researchers have shown that three doses over two days of the drug artesunate are as effective in killing the malaria parasite in the blood as five doses over three days.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).
A small blood lab that fits into the pocket of a jacket can quickly analyze the risk of blood clots in legs prior to a long distance flight; a sensor wristband for measuring electric smog can warn pacemaker patients of life-threatening exposure: "Smart plastics" can turn such tools into reality.
Even though the use of implantable devices for the treatment of heart failure and heart rhythm disturbances has increased enormously in Europe in recent years, there still remain large differences between countries. Indeed, a report last year in the European Journal of Heart Failure found that there is an underuse of devices in many of the European countries surveyed. This is especially so in the emerging economies of Eastern Europe.
First peer-reviewed publication on US trial results from Houston Methodist published in The American Journal of Pathology
› Verified 8 days ago
| Entity Name | Greater Florida Anesthesiologists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528630795 PECOS PAC ID: 3173711017 Enrollment ID: O20101220000829 |
News Archive
A shorter anti-malaria treatment is as effective in treating seriously ill children as the standard regimen, according to new research. Researchers have shown that three doses over two days of the drug artesunate are as effective in killing the malaria parasite in the blood as five doses over three days.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).
A small blood lab that fits into the pocket of a jacket can quickly analyze the risk of blood clots in legs prior to a long distance flight; a sensor wristband for measuring electric smog can warn pacemaker patients of life-threatening exposure: "Smart plastics" can turn such tools into reality.
Even though the use of implantable devices for the treatment of heart failure and heart rhythm disturbances has increased enormously in Europe in recent years, there still remain large differences between countries. Indeed, a report last year in the European Journal of Heart Failure found that there is an underuse of devices in many of the European countries surveyed. This is especially so in the emerging economies of Eastern Europe.
First peer-reviewed publication on US trial results from Houston Methodist published in The American Journal of Pathology
› Verified 8 days ago
| Entity Name | Ams National Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316330830 PECOS PAC ID: 3870813025 Enrollment ID: O20150529000613 |
News Archive
A shorter anti-malaria treatment is as effective in treating seriously ill children as the standard regimen, according to new research. Researchers have shown that three doses over two days of the drug artesunate are as effective in killing the malaria parasite in the blood as five doses over three days.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).
A small blood lab that fits into the pocket of a jacket can quickly analyze the risk of blood clots in legs prior to a long distance flight; a sensor wristband for measuring electric smog can warn pacemaker patients of life-threatening exposure: "Smart plastics" can turn such tools into reality.
Even though the use of implantable devices for the treatment of heart failure and heart rhythm disturbances has increased enormously in Europe in recent years, there still remain large differences between countries. Indeed, a report last year in the European Journal of Heart Failure found that there is an underuse of devices in many of the European countries surveyed. This is especially so in the emerging economies of Eastern Europe.
First peer-reviewed publication on US trial results from Houston Methodist published in The American Journal of Pathology
› Verified 8 days ago
| Entity Name | Orthomed Staffing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225514276 PECOS PAC ID: 9638429178 Enrollment ID: O20230910000139 |
News Archive
A shorter anti-malaria treatment is as effective in treating seriously ill children as the standard regimen, according to new research. Researchers have shown that three doses over two days of the drug artesunate are as effective in killing the malaria parasite in the blood as five doses over three days.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).
A small blood lab that fits into the pocket of a jacket can quickly analyze the risk of blood clots in legs prior to a long distance flight; a sensor wristband for measuring electric smog can warn pacemaker patients of life-threatening exposure: "Smart plastics" can turn such tools into reality.
Even though the use of implantable devices for the treatment of heart failure and heart rhythm disturbances has increased enormously in Europe in recent years, there still remain large differences between countries. Indeed, a report last year in the European Journal of Heart Failure found that there is an underuse of devices in many of the European countries surveyed. This is especially so in the emerging economies of Eastern Europe.
First peer-reviewed publication on US trial results from Houston Methodist published in The American Journal of Pathology
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donna Baker, CRNA 110 West Rd, Suite210, Towson, MD 21204-2316 Ph: (410) 296-4616 | Donna Baker, CRNA 6701 N Charles St, Towson, MD 21204-6808 Ph: (410) 296-4616 |
News Archive
A shorter anti-malaria treatment is as effective in treating seriously ill children as the standard regimen, according to new research. Researchers have shown that three doses over two days of the drug artesunate are as effective in killing the malaria parasite in the blood as five doses over three days.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).
A small blood lab that fits into the pocket of a jacket can quickly analyze the risk of blood clots in legs prior to a long distance flight; a sensor wristband for measuring electric smog can warn pacemaker patients of life-threatening exposure: "Smart plastics" can turn such tools into reality.
Even though the use of implantable devices for the treatment of heart failure and heart rhythm disturbances has increased enormously in Europe in recent years, there still remain large differences between countries. Indeed, a report last year in the European Journal of Heart Failure found that there is an underuse of devices in many of the European countries surveyed. This is especially so in the emerging economies of Eastern Europe.
First peer-reviewed publication on US trial results from Houston Methodist published in The American Journal of Pathology
› Verified 8 days ago
Monika Harold, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 443-849-3880 | |
Terri Bonsall, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 410-296-4616 Fax: 410-337-5068 | |
Rita Kesselman, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7601 Osler Dr, Towson, MD 21204 Phone: 410-337-4501 | |
Tim Ngoc Dinh, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St Ste 4226, Towson, MD 21204 Phone: 410-296-4616 Fax: 410-337-5068 | |
Thomas Curry, C.R.N.A. Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 410-296-4616 Fax: 410-337-5068 | |
Barbara Rogers, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1122 Kenilworth Dr, Suite 317, Towson, MD 21204 Phone: 410-296-4616 Fax: 410-337-5068 | |
Francis Equale, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 6701 N Charles St, Towson, MD 21204 Phone: 410-296-4616 Fax: 410-337-5068 |